Büttelborn, Germany

Mike Brandner

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Merck Patent Gmbh. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mike Brandner. Retrieved from https://idiyas.com/inventor/mike-brandner-89xnqowy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Mike Brandner

Introduction

Mike Brandner, a notable inventor based in Büttelborn, Germany, has made significant contributions to the field of chemistry through his innovative processes. With a focus on nicotinaldehydes, his patented invention showcases the intersection of science and practical application in the pharmaceutical industry.

Latest Patents

Mike holds a patent for a "Process for the preparation of nicotinaldehydes." This invention pertains to a method of reducing the corresponding nicotinic acid morpholinamides, marking an important advancement in the synthesis of these compounds.

Career Highlights

Brandner is associated with Merck Patent GmbH, a company renowned for its focus on science and technology. His role there emphasizes the application of innovative processes in the development of pharmaceutical products.

Collaborations

Throughout his career, Mike has worked alongside esteemed colleagues, including Heinz-Hermann Bokel and Ludwig Gantzert. These collaborations have been pivotal in fostering a rich environment for innovation and advancing research in their field.

Conclusion

In conclusion, Mike Brandner's work exemplifies the essence of innovation in the chemical industry. His patented processes not only contribute to the scientific community but also enhance the capabilities of Merck Patent GmbH, signaling a promising path for future advancements in pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…